1. Home
  2. LXEO vs TBI Comparison

LXEO vs TBI Comparison

Compare LXEO & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • TBI
  • Stock Information
  • Founded
  • LXEO 2017
  • TBI 1985
  • Country
  • LXEO United States
  • TBI United States
  • Employees
  • LXEO N/A
  • TBI N/A
  • Industry
  • LXEO
  • TBI Professional Services
  • Sector
  • LXEO
  • TBI Consumer Discretionary
  • Exchange
  • LXEO Nasdaq
  • TBI Nasdaq
  • Market Cap
  • LXEO 252.4M
  • TBI 248.3M
  • IPO Year
  • LXEO 2023
  • TBI 1996
  • Fundamental
  • Price
  • LXEO $4.88
  • TBI $7.88
  • Analyst Decision
  • LXEO Strong Buy
  • TBI Buy
  • Analyst Count
  • LXEO 5
  • TBI 2
  • Target Price
  • LXEO $23.80
  • TBI $11.50
  • AVG Volume (30 Days)
  • LXEO 210.0K
  • TBI 162.9K
  • Earning Date
  • LXEO 01-28-2025
  • TBI 02-19-2025
  • Dividend Yield
  • LXEO N/A
  • TBI N/A
  • EPS Growth
  • LXEO N/A
  • TBI N/A
  • EPS
  • LXEO N/A
  • TBI N/A
  • Revenue
  • LXEO N/A
  • TBI $1,673,611,000.00
  • Revenue This Year
  • LXEO N/A
  • TBI N/A
  • Revenue Next Year
  • LXEO N/A
  • TBI N/A
  • P/E Ratio
  • LXEO N/A
  • TBI N/A
  • Revenue Growth
  • LXEO N/A
  • TBI N/A
  • 52 Week Low
  • LXEO $4.78
  • TBI $6.63
  • 52 Week High
  • LXEO $19.50
  • TBI $14.91
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 29.67
  • TBI 49.95
  • Support Level
  • LXEO $4.78
  • TBI $7.15
  • Resistance Level
  • LXEO $7.66
  • TBI $8.20
  • Average True Range (ATR)
  • LXEO 0.56
  • TBI 0.35
  • MACD
  • LXEO -0.17
  • TBI -0.01
  • Stochastic Oscillator
  • LXEO 3.47
  • TBI 51.77

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.

Share on Social Networks: